drugs only module 12-14 Flashcards
what are the classes of drugs to treat elevated blood lipids?
statins bile acid sequestrants nicotinic acid cholesterol absorption ihibitors fibric acid derivatives (fibrates)
atorvastatin
low oral bioavailability (14%)
large fraction of absorbed does is extracted by the liver (site of action)
distrib primarily to liver but also to spleen, adrenal glands, & skeletal muscle
metabolized by CYP3A4
elminated in feces
rosuvastatin
low oral bioavailability (20%)
large fraction of absorbed does is extracted by the liver (site of action)
distrib primarily to liver but also to skeletal muscle
not extensively metabolized
elminated in feces
*plasma concentrations approx. 2x higher in asian patients compared to caucasian - the initial dose should be 5mg and caution to be used when increasing dose
adverse effects of statins
generally well-tolerated
myopathy (muscle injury)
rhabodomyolysis rare but serious - muscle lysis with severe muscle pain & diagnosed with high levels of creatine kinase. it’s also accompanied by high levels of potassium which can lead to kidney problems
hepatotoxicity - possible but low incidence
*teratogen as cholesterol required for synth of cell membranes & many hormones
nicotinic acid
inhibits hepatic secretion of VLDL. Since, LDL is a by-product of VLDL degredation, this drug effectively reduces both
increases blood HDL levels
side effects: intense facial flushing, hepatotoxicity, hyperglycemia, skin rash, increased uric acid levels
bile acid sequestrants
large + charged molecules that attract and bind bile acids (neg charged), preventing their absorption
causes increased demand for bile acid synth in liver which uses LDL cholesterol
liver increase # of LDL receptors, increasing uptake of LDL from blood
adverse effects: limited to GI tract - constipation and bloating
also, may decrease the absorption of some drugs that are neg. charged such as thiazide diuretics, digoxin, warfarin, and certain antibiotics
ezetimibe (Zetia)
cholesterol absorption inhibitor
inhibits transport protein NPC1L1 which absorbs dietary cholesterol
lowers blood LDL cholesterol 15-20%
can produce a compensatory increase in hepatic cholesterol synth so usually an adjunct therapy used with a statin
*there is a combo pill called vytorin which contains a statin and ezetimibe (can reduce LDL cholesterol up to 60%)
Fibric Acid Derivatives (Fibrates)
most effective class for lowering plasma triglyceride levels
they also increase HDL, no effect on LDL
bind to PPARalpha in liver
effects of activating PPAR alpha:
1.increased synth of enzyme lipoprotein lipase (gets rid of triglycerides)
2.decreased apolipoprotein C-III production (which normally inhibits lipoprotein lipase)
3. increased apolipoprotein A-I and apolipoprotein A-II levels - increases HDL levels
adverse effects of fibrates
increased risk of gallstones
myopathy
hepatotoxicity
*fibrates & statins have some of the same adverse efects so pt.s on both need to be monitored for side effects
Loop diuretics
antihypertensive
most effective diuretic
block sodium and chloride ion reabsorption in the thick ascending limb of the loop of henle
reserved for situations requiring rapid loss of fluid like edma, severe hypertension not responding to other diuretics, severe renal failure
adverse effects of loop diuretics
hypokalemia (can cause fatal cardiac dysrhythmias)
hypoatremia
dehydration
hypotension
thiazide diuretics
most common drug for HTN
2 mech: 1. block sodium and chloride ion reabsorption in distal tubule 2. decreasing vascular resistance
adverse effects of thiazide diuretics
hypokalemia (can cause fatal cardiac dysrhythmias)
dehydration
hyponatremia
potassium sparing diuretics/aldosterone atnagonists
minimal lowering of BP
inhibit aldosterone receptors in collecting duct
blocking these receptors causes increased sodium excretion and potassium retention
main use is in combo with loop or thiazide diuretics to counteract potential hypokalemia side effect
NOT to be used with ACE inhibitors or renin inhibitors as these drugs conserve potassium
adverse effects of potassium sparing diuretics/aldosterone atnagonists
hyperkalemia (can cause fatal cardiac dysrhythmias)
beta blockers
tx HTN
“olol”
antagonist
2 mech: 1.block cardiac beta 1 receptors - as blocks binding of catecholamines therefore decreasing CO 2.blocks beta 1 receptors juxtaglomerular cells -blocks renin release which decreases RAAS mediated vasoconstriction therefore decreasing peripheral resistance
what is the difference between 1st and 2nd generation beta blockers?
1st gen - inhibit both beta 1 and beta 2 - beta 2 found in lung and can be problematic for those with lung issues
2nd gen- selective for beta 1 receptors
adverse effects of beta blockers
selective beta 1: bradycardia, decreased CO, heart failure (rare), rebound hypertension if withdrawn abruptly
non-selective: bronchoconstriction, inhibition of hepatic and muscle glycogenolysis
Angiotensin Converting Enzyme (ACE) inhibitors
tx HTN
“pril”
2 mech: 1.decreased production of angiotensin II therefore causing vasodilation and decreased blood vol therefore decrease CO and peripheral resistance 2.inhibit the breakdown of bradykinin - having more bradykinin causes vasodilation
adverse effects of ACE inhibitors
generally well tolerated
side effects from decreased angiotensin II - first dose hypotension, hyperkalemia
side effects from increased bradykinin: persistent cough, angioedema
*use with certain NSAIDs may decrease effect of ACE inhibitors
Angiotensin Receptor Blockers (ARBs)
tx HTN
“sartan”
block binding of angiotensin II to recptor AT1
cause vasodilation as blocking effect of angiotensin II
also decrease aldosterone release from adrenal cortex causing increase water and sodium excretion
adverse effects of ARBs
not really any significant adverse effects
low risk of angioedema
Direct Renin Inhibitors (DRIs)
bind to renin and block the conversion of angiotensinogen to angiotensin I
influences entire RAAS pathway
BP lowering effect similar to other HTN drugs
adverse effects of DRIs
hyperkalemia - should not be taken with other drugs that may cause hyperkalemia and no potassium supplements
very low incidence of persisten cough and angioedema
diarrhea
calcium channel blockers
tx HTN
calcium essential for contraction
blocks calcium from entering heart and smooth muscle cells, decreasing contraction
2 categories: dihydropyridine calcium channel blockers and non-dihydropyridine calcium channel blockers
dihydropyridine calcium channel blockers
“dipine”
significantly decrease calcium influx into cmooth muscle of arteries leads to relaxation of muscles = vasodilation
-therapeutic doses don’t act on heart
adverse effects of dihydropyridine calcium channel blockers
flushing, dizziness, headache, peripheral edema, reflex tachycardia, rash
non-dihydropyridine calcium channel blockers
block calcium influx in heart and smooth muscles of arteries
decrease peripheral resistance and CO
adverse effects of non-dihydropyridine calcium channel blockers
constipation dizziness flushing headache edema may compromise cardiac function
Centrally Acting Alpha 2 agonists
bind to and activate alpha 2 receptors in the brainstem
decreases sympathetic outflow to heart and blood vessels
inhibiting sympathetic outflow decreases peripheral resistance and CO
adverse effects of Centrally Acting Alpha 2 agonists
drowsiness
dry mouth
rebound HTN if withdrawn abruptly
Levodopa (L-Dopa)
tx of parkinson’s disease
dopamine replacement
most effective drug for PD
crosses BBB
inactive until converted to dopamin in dopaminergic nerve terminals mediated by decarboxylase enzymes
cofactor pyridoxine (vit B6) speeds up reaction
*usually given with carbidopa which inhibits peripheral metabolism mediated by decarboxylase enzymes so more L-Dopa reaches the brain (10%)
adverse effects of L-Dopa
nausea and vomiting dyskinesias cardiac dysrhythmias orthostatic hypotension psychosis
may experience 2 types of loss of effect:
1 - wearing off - gradual loss of effect
2. on-off - abrupt loss of effect